Clinical Trial Study - Diabetic Macular Oedema (DME)
The Queensland Eye Institute is currently recruiting for patients with macular oedema due to diabetic macular oedema (DME). It is a Phase 4 progressive study of a treatment currently available to patients. The aim of this trial is to show the treatment is able to reduce the progression of the condition and prevent related vision loss. Participants will receive a treatment injection in their effected eyes for 12 months. Principal Investigator Associate Professor Anthony Kwan.
Amblyopia is a neurodevelopmental disorder of vision typically manifesting as reduced visual acuity in one eye and abnormal binocular function. Current treatments for amblyopia are usually administered in childhood and include occlusion or “patching”. This trial involves treatment using a prototype device (the Amblyoptica device) The device is worn in a manner like spectacles. The purpose of this trial is to assess if there is any improvement in visual acuity and binocular function in people with amblyopia (Lazy Eye).
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 years of age. In the wet form of AMD, abnormal blood vessels grow in the back of the eye leaking blood or fluid that causes blurred or distorted vision. The Queensland Eye Institute is currently involved in a phase 1 clinical trial that aims to evaluate the safety, tolerability, and efficacy of a drug called axitinib in the OTX-TKI implant in participants with wet AMD. The principal investigator involved in this study is A/Prof Anthony Kwan and the associate investigator involved is Dr Abhishek Sharma.
Choosing to participate in a clinical trial is an important personal decision. Talk with your GP, local health care professional and family members before deciding to join a trial. To learn more about any of these studies, you or your doctor may contact the study research staff on 07 3239 5000 or email:
For all studies, to enable our QEI Ophthalmologist to confirm diagnosis a referral from your Optometrist, General Practitioner or Ophthalmologist is required prior to registering your interest at the Queensland Eye Institute.